BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Genetown

  ConforMIS Wants to Win Share by Providing Customized Knee Implants

  August 3, 2012

   · 

  1 min read
• Drug Development

  BioDelivery Sciences International and Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain

  August 3, 2012

   · 

  6 min read
• Catalyst Pharmaceutical Partners, Inc. Regains Compliance With NASDAQ Minimum Bid Price Rule

  August 3, 2012

   · 

  1 min read
• Business

  NeurogesX, Inc. Reports Second Quarter 2012 Results

  August 3, 2012

   · 

  1 min read
• Drug Development

  New Published Data Demonstrate Endocyte, Inc.'s Targeted Small Molecule Drug Conjugate Approach Shows Promising Results in Polycystic Kidney Disease Model

  August 3, 2012

   · 

  1 min read
• Business

  Mylan Inc. Signs Agreement with Gilead Sciences, Inc. to Accelerate Access to Generic Single and Fixed-Dose Combination ARVs Containing Emtricitabine

  August 3, 2012

   · 

  3 min read
• Bioheart, Inc. Renegotiates Company Note With Favorable Terms

  August 3, 2012

   · 

  3 min read
• Biotech Bay

  Accuray Inc. Announces First CyberKnife System in South America

  August 3, 2012

   · 

  5 min read
• Immucor Updates Debt Investor Conference Call to Tuesday, August 7

  August 3, 2012

   · 

  1 min read
• Business

  MethylGene Reports Second Quarter 2012 Financial Results and Provides an Update on its Clinical Programs

  August 3, 2012

   · 

  9 min read